About Protein PRRC1
Protein PRRC1 (PRRC1) is a protein
from Homo sapiens identified by UniProt accession
Q96M27, 445 residues long.
MolForge cross-references it against 0 known binders and
12 disease associations.
Target properties
| Protein name | Protein PRRC1 |
|---|
| UniProt accession | Q96M27 |
|---|
| Gene | PRRC1 |
|---|
| Organism | Homo sapiens |
|---|
| Length | 445 residues |
|---|
| Molecular weight | — |
|---|
| EC numbers | — |
|---|
| Target class | UNCLASSIFIED |
|---|
| Subcellular location | — |
|---|
| Keywords | — |
|---|
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|
| Druggability score | — |
|---|
| Pocket score | — |
|---|
| Max clinical phase | — |
|---|
Disease associations (12)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.25
- body height · score 0.23
- Cluster headache · score 0.21
- response to antipsychotic drug · score 0.11
- Red cell distribution width · score 0.03
- ovarian carcinoma · score 0.01
- acute quadriplegic myopathy · score 0.00
- Acute Leukemia · score 0.00
- invasive breast ductal carcinoma · score 0.00
- BK-virus nephropathy · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|
| AF-Q96M27-F1 | alphafold | PREDICTED | 67.75 | — |
Amino-acid sequence (445 residues)
MMEESGIETT PPGTPPPNPA GLAATAMSST PVPLAATSSF SSPNVSSMES FPPLAYSTPQ PPLPPVRPSA PLPFVPPPAV PSVPPLVTSM PPPVSPSTAA AFGNPPVSHF PPSTSAPNTL LPAPPSGPPI SGFSVGSTYD ITRGHAGRAP QTPLMPSFSA PSGTGLLPTP ITQQASLTSL AQGTGTTSAI TFPEEQEDPR ITRGQDEASA GGIWGFIKGV AGNPMVKSVL DKTKHSVESM ITTLDPGMAP YIKSGGELDI VVTSNKEVKV AAVRDAFQEV FGLAVVVGEA GQSNIAPQPV GYAAGLKGAQ ERIDSLRRTG VIHEKQTAVS VENFIAELLP DKWFDIGCLV VEDPVHGIHL ETFTQATPVP LEFVQQAQSL TPQDYNLRWS GLLVTVGEVL EKSLLNVSRT DWHMAFTGMS RRQMIYSAAR AIAGMYKQRL PPRTV
Explore Protein PRRC1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets